Bristol Myers Squibb (BMY) FCF Margin (2009 - 2026)
Bristol Myers Squibb (BMY) reported FCF Margin of 6.59% for Q1 2026, down 853.0% year-over-year from 0.88% in Q1 2025, and down 48.64% on a QoQ basis from 12.83% in Q4 2025.
Bristol Myers Squibb (BMY) has 18 years of FCF Margin data on file, last reported at 6.59% in Q1 2026.
- Quarterly FCF Margin fell 853.0% year-over-year to 6.59% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 24.56% (down 291.0% YoY) and the FY2025 annual result came in at 26.65%, down 221.0% from the prior year.
- FCF Margin fell to 6.59% in Q1 2026 per BMY's latest filing, from 12.83% in the prior quarter.
- Across five years, FCF Margin topped out at 49.02% in Q3 2025 and bottomed at 6.59% in Q1 2026.
- The 5-year median for FCF Margin is 25.95% (2022), against an average of 26.16%.
- Peak annual rise in FCF Margin reached 1207 bps in 2025, while the deepest fall reached 2007 bps in 2025.
- Tracing BMY's FCF Margin over 5 years: stood at 25.95% in 2022, then soared by 32 bps to 34.17% in 2023, then fell by 4 bps to 32.9% in 2024, then slumped by 61 bps to 12.83% in 2025, then sank by 49 bps to 6.59% in 2026.
- Per Business Quant, the three latest BMY FCF Margin figures stand at 6.59% (Q1 2026), 12.83% (Q4 2025), and 49.02% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 15.19% |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 6.09% |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 23.76% |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 17.97% |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 17.14% |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 34.87% |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 93.16% |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 6.59% |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.59% |
| Dec 31, 2025 | 12.83% |
| Sep 30, 2025 | 49.02% |
| Jun 30, 2025 | 28.98% |
| Mar 31, 2025 | 15.12% |
| Dec 31, 2024 | 32.90% |
| Sep 30, 2024 | 44.29% |
| Jun 30, 2024 | 16.92% |
| Mar 31, 2024 | 21.49% |
| Dec 31, 2023 | 34.17% |
| Sep 30, 2023 | 40.21% |
| Jun 30, 2023 | 14.50% |
| Mar 31, 2023 | 23.75% |
| Dec 31, 2022 | 25.95% |
| Sep 30, 2022 | 30.67% |
| Jun 30, 2022 | 16.73% |
| Mar 31, 2022 | 30.55% |
| Dec 31, 2021 | 31.18% |
| Sep 30, 2021 | 42.98% |
| Jun 30, 2021 | 24.35% |
| Mar 31, 2021 | 32.97% |
| Dec 31, 2020 | 27.76% |
| Sep 30, 2020 | 20.06% |
| Jun 30, 2020 | 43.06% |
| Mar 31, 2020 | 34.79% |
| Dec 31, 2019 | 24.29% |
| Sep 30, 2019 | 39.39% |
| Jun 30, 2019 | 30.16% |
| Mar 31, 2019 | 20.03% |
| Dec 31, 2018 | 54.66% |
| Sep 30, 2018 | 18.54% |
| Jun 30, 2018 | 15.06% |
| Mar 31, 2018 | 18.02% |
| Dec 31, 2017 | 15.84% |
| Sep 30, 2017 | 27.62% |
| Jun 30, 2017 | 25.97% |
| Mar 31, 2017 | 11.56% |
| Dec 31, 2016 | 20.45% |
| Sep 30, 2016 | 21.60% |
| Jun 30, 2016 | 3.65% |
| Mar 31, 2016 | -10.70% |
| Dec 31, 2015 | 13.97% |
| Sep 30, 2015 | 7.13% |
| Jun 30, 2015 | -2.26% |
| Mar 31, 2015 | 12.13% |
| Dec 31, 2014 | 8.95% |
| Sep 30, 2014 | 20.30% |
| Jun 30, 2014 | 24.33% |
| Mar 31, 2014 | 13.09% |
| Dec 31, 2013 | 27.25% |
| Sep 30, 2013 | 22.85% |
| Jun 30, 2013 | 34.88% |
| Mar 31, 2013 | -14.17% |
| Dec 31, 2012 | 15.77% |
| Sep 30, 2012 | 119.03% |
| Jun 30, 2012 | 22.98% |
| Mar 31, 2012 | 5.03% |
| Dec 31, 2011 | 26.29% |
| Sep 30, 2011 | 30.20% |
| Jun 30, 2011 | 18.75% |
| Mar 31, 2011 | 8.10% |
| Dec 31, 2010 | 28.76% |
| Sep 30, 2010 | 26.97% |
| Jun 30, 2010 | 20.30% |
| Mar 31, 2010 | 6.97% |
| Dec 31, 2009 | 22.81% |
| Sep 30, 2009 | 27.23% |